BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11344828)

  • 1. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
    Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
    Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism.
    Oren R; Dotan I; Papa M; Marravi Y; Aeed H; Barg J; Zeidel L; Bruck R; Halpern Z
    Hepatology; 1996 Aug; 24(2):419-23. PubMed ID: 8690414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
    Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J
    Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental cirrhosis in rats by HD-03.
    Mitra SK; Udupa UV; Sheshadri SJ; Venkataranganna MV; Gopumadhavan S; Anturlikar SD
    Acta Pharmacol Sin; 2000 Sep; 21(9):777-81. PubMed ID: 11501156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats.
    Cruz A; Padillo FJ; Torres E; Navarrete CM; Muñoz-Castañeda JR; Caballero FJ; Briceño J; Marchal T; Túnez I; Montilla P; Pera C; Muntané J
    J Pineal Res; 2005 Sep; 39(2):143-50. PubMed ID: 16098091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide].
    An JH; Seong J; Oh H; Kim W; Han KH; Paik YH
    Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure.
    Bruck R; Oren R; Shirin H; Aeed H; Papa M; Matas Z; Zaidel L; Avni Y; Halpern Z
    Hepatology; 1998 Apr; 27(4):1013-20. PubMed ID: 9537441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of nuclear factor kappaB and transforming growth factor beta1 in the anti-liver fibrosis process using Ginkgo biloba extract].
    Liu SQ; Yu JP; He L; Yu HG; Luo HS
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):903-7. PubMed ID: 16381635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
    Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J
    J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats.
    Mu Y; Liu P; Du G; Du J; Wang G; Long A; Wang L; Li F
    J Ethnopharmacol; 2009 Jan; 121(1):35-42. PubMed ID: 18996463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
    Haider S; Saleem S; Shameem S; Ahmed SP; Parveen T; Haleem DJ
    Pol J Pharmacol; 2004; 56(1):73-8. PubMed ID: 15047980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models.
    Natarajan SK; Thomas S; Ramamoorthy P; Basivireddy J; Pulimood AB; Ramachandran A; Balasubramanian KA
    J Gastroenterol Hepatol; 2006 Jun; 21(6):947-57. PubMed ID: 16724977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced hypothyroidism accelerates the regression of liver fibrosis in rats.
    Bruck R; Weiss S; Traister A; Zvibel I; Aeed H; Halpern Z; Oren R
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2189-94. PubMed ID: 18031379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of carnosine in preventing thioacetamide-induced liver injury in the rat.
    Mehmetçik G; Ozdemirler G; Koçak-Toker N; Cevikbaş U; Uysal M
    Peptides; 2008 Mar; 29(3):425-9. PubMed ID: 18164100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA; Theocharis SE; Mikros E
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.